Nadia shares her journey with breast cancer and infertility, as well as her treatment plan with Perimeter's technology.
Mary discusses her breast cancer diagnosis and involvement in a clinical trial using Perimeter’s technology.
Jessie discusses her breast cancer diagnosis and involvement in a clinical trial using Perimeter’s technology.
Hear Suzanne talk about the fear she experienced with her cancer diagnosis and being called back for a second surgery.
Jenn describes how her battle with cancer affected her outlook on life.
Jenn’s year-long cancer journey included repeat surgeries to remove all of the cancer, resulting in delayed treatment and emotional trauma.
The Claire OCT System is an adjunctive three-dimensional imaging tool which provides volumetric cross-sectional, real-time depth visualization, coupled with an artificial intelligence computer aided detection algorithm which identifies and marks focal areas suspicious for breast cancer and is used concurrently with physician interpretation of the images.
The Claire OCT System is intended for use in conjunction with other standard methods for evaluation of the margins of excised lumpectomy tissue during surgical procedures in patients with a biopsy-confirmed diagnosis of breast cancer. The Claire OCT System is an adjunctive tool; it does not replace standard tissue histopathology nor provide a diagnosis.
The S-Series OCT has 510(k) clearance under a general indication and has not been evaluated by FDA specifically for use in breast tissue, breast cancer, other types of cancer, margin evaluation, and reducing re-excision rates. More information here.
Neither Claire nor S-Series OCT system is available for sale outside the USA.